Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,022 | 0 | 0 | 0 | 2,449 |
| Receivables | 323 | 0 | 0 | 0 | 361 |
| Other current assets | 0 | 0 | 0 | 0 | 283 |
| TOTAL | $9,757 | $0 | $0 | $0 | $3,093 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 56 | 0 | 0 | 0 | 51 |
| TOTAL | $56 | $N/A | $N/A | $N/A | $51 |
| Total Assets | $9,813 | $0 | $0 | $0 | $3,144 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 0 | 0 | 116 |
| Accounts payable and accrued liabilities | 554 | 0 | 0 | 0 | 597 |
| Accrued Expenses | 811 | 0 | 0 | 0 | 304 |
| TOTAL | $1,365 | $0 | $0 | $0 | $1,759 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,365 | $0 | $0 | $0 | $1,759 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 0 | 0 | 0 | 7 |
| Retained earnings | -46,026 | 0 | 0 | 0 | -41,258 |
| Other shareholders' equity | -384 | 0 | 0 | 0 | 305 |
| TOTAL | $8,448 | $0 | $0 | $0 | $1,385 |
| Total Liabilities And Equity | $9,813 | $0 | $0 | $0 | $3,144 |